Rankings
▼
Calendar
EYPT Q3 2016 Earnings — EyePoint Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
EYPT
EyePoint Pharmaceuticals, Inc.
$1B
Q3 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$277,000
Gross Profit
-$3M
-1250.9% margin
Operating Income
-$7M
-2594.2% margin
Net Income
-$7M
-2585.6% margin
EPS (Diluted)
$-2.10
QoQ Revenue Growth
-8.9%
Cash Flow
Operating Cash Flow
-$6M
Free Cash Flow
-$6M
Stock-Based Comp.
$734,000
Balance Sheet
Total Assets
$25M
Total Liabilities
$10M
Stockholders' Equity
$14M
Cash & Equivalents
$14M
← Q2 2016
All Quarters
Q4 2016 →
